Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cytokinetics (CYTK) Other Non Operating Income (2022 - 2025)

Cytokinetics (CYTK) has disclosed Other Non Operating Income for 3 consecutive years, with -$300000.0 as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income changed N/A to -$300000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.7 million through Dec 2025, changed N/A year-over-year, with the annual reading at -$200000.0 for FY2025, 115.38% down from the prior year.
  • Other Non Operating Income for Q4 2025 was -$300000.0 at Cytokinetics, up from -$2.8 million in the prior quarter.
  • The five-year high for Other Non Operating Income was $700000.0 in Q3 2024, with the low at -$3.0 million in Q2 2025.
  • Average Other Non Operating Income over 3 years is -$1.0 million, with a median of -$300000.0 recorded in 2025.
  • Peak annual rise in Other Non Operating Income hit 500.0% in 2025, while the deepest fall reached 600.0% in 2025.
  • Over 3 years, Other Non Operating Income stood at -$2.7 million in 2022, then soared by 125.99% to $700000.0 in 2024, then plummeted by 142.86% to -$300000.0 in 2025.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at -$300000.0, -$2.8 million, and -$3.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.